Leaflet: information for the user
Apogrip powder for oral solution
Paracetamol / Phenylephrine hydrochloride / Chlorphenamine maleate
Read this leaflet carefully before you start to take this medicine, because it contains important information for you.
Follow exactly the administration instructions of the medicine contained in this leaflet or those indicated by your doctor, or pharmacist.
- Keep this leaflet, as you may have to read it again.
- If you need advice or more information, consult your pharmacist.
- If you experience any side effects, consult your doctor or pharmacist even if they are not listed in this leaflet.
- You should consult a doctor if it worsens or does not improve or if the fever persists for more than 3 days or the pain for more than 5 days.
l
It is an association of paracetamol, chlorphenamine, and phenylephrine.
Paracetamol is an analgesic that reduces pain and fever.
Chlorphenamine is an antihistamine that alleviates nasal secretion.
Phenylephrine is a sympathomimetic that reduces nasal congestion.
It is indicated for the relief of symptoms of colds and flu that are accompanied by fever or mild to moderate pain, congestion, and nasal secretion, in adults and adolescents 12 years of age and older.
Consult a doctor if symptoms worsen or do not improve or if fever persists for more than 3 days or pain for more than 5 days.
Do not take Apogrip
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication.
Children and adolescents
Children under 12 years old cannot take this medication.
Other medications and Apogrip
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Interference with analytical tests:
Taking Apogrip powder with food, drinks, and alcohol
While taking this medication, do not consume alcoholic beverages, as it may potentiate the appearance of adverse effects of this medication.
Additionally, the use of medications containing paracetamol by patients who regularly consume alcohol (3 or more alcoholic beverages: beer, wine, liquor... per day) may cause liver damage.
The medication can be taken with or without food.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before taking this medication.
This medication should not be taken during pregnancy unless your doctor considers it strictly necessary.
If necessary, Apogrip can be used during pregnancy. Use the lowest possible dose that reduces pain or fever and use it for the shortest possible time. Contact your doctor or midwife if the pain or fever do not decrease or if you need to take the medication more frequently.
This medication cannot be taken by mothers during breastfeeding, as it may cause adverse effects in the baby.
Driving and operating machinery
This medication may cause drowsiness. If you experience drowsiness during treatment with this medication, avoid driving vehicles or operating machinery.
Apogrip sachets contain saccharose
Apogrip contains 3.994 g of saccharose in each sachet, which should be taken into account by patients with hereditary fructose intolerance, glucose/galactose absorption problems, saccharose-isomaltase deficiency, and diabetic patients.
Follow these medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. If you have any doubts, ask your doctor or pharmacist.
The recommended dose is:
Adults and adolescents 12 years of age and older: 1 tablet every 6-8 hours as needed (3 or 4 tablets a day). Do not take more than 3 grams of paracetamol per day (4 tablets) every 24 hours.
Patients with liver insufficiency:These patients cannot take more than 1 tablet every 8 hours. In no case can they take more than 3 tablets a day.
Patients with renal insufficiency:They cannot take this medication due to the paracetamol dose.
Use in children
This medication is contraindicated in children under 12 years of age.
Use in elderly people
Elderly people cannot use this medication without consulting their doctor because they may be especially affected by some side effects of the medication, such as the appearance of slow heartbeats (bradycardia) or reduced cardiac output, due to the content of phenylephrine and chlorphenamine. They are also more likely to present side effects such as sedation, confusion, hypotension, or excitement and may be more sensitive to effects such as dry mouth and urinary retention.
How to take
Apogrip is taken orally.
Dissolve the contents of the packet completely in a little liquid, preferably half a glass of water and then drink.
Always take the smallest effective dose.
The taking of this medication is subject to the appearance of symptoms. As they disappear, the treatment should be suspended.
If the fever persists for more than 3 days of treatment, the pain or other symptoms for more than 5 days, or worsen or new symptoms appear, you should consult your doctor.
If you take more Apogrip than you should
If you have ingested an overdose, you should go immediately to a medical center, even if you do not feel the symptoms, as they often do not appear until 3 days after ingestion of the overdose, even in cases of severe poisoning.
The symptoms of an overdose may be: dizziness, vomiting, loss of appetite, yellowish discoloration of the skin and eyes (jaundice) and abdominal pain. Anxiety, fear, agitation, headache (may be a symptom of high blood pressure), convulsions, insomnia (or intense somnolence), clumsiness, feeling of fainting, instability, confusion, irritability, tremors, anorexia; psychosis with hallucinations (this last especially in children). Dry mouth, nose, or throat. An overdose can also cause: coagulation disorders (blood clots and hemorrhages).
Effects such as high blood pressure, arrhythmias (rapid or irregular heartbeats), palpitations, reduced urine production. Metabolic acidosis (decrease in blood alkalinity reserve). In prolonged use, depletion of plasma volume (decrease in blood volume) may occur.
The treatment of an overdose is more effective if it is initiated within 4 hours of taking the overdose of the medication.
Patients undergoing barbiturate treatment or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
In case of overdose or accidental ingestion, go immediately to a medical center or call the Toxicological Information Service (Telephone 91 562 04 20), indicating the medication and the amount ingested.
Do not take a double dose to compensate for missed doses.
Like all medicines, Apogrip may cause side effects, although not everyone will experience them.
During the period of use of paracetamol, phenylephrine, and chlorphenamine, the following side effects have been reported, whose frequency has not been established with precision:
Nervous excitement (usually with high doses, and is more frequent in elderly patients and children), which may include symptoms such as: restlessness, insomnia, nervousness, and even convulsions. Other side effects that may appear with low frequency are: chest tightness, lung noises, rapid or irregular heartbeats (usually with overdose), liver disorders (which may present with stomach or abdominal pain, dark urine, or other symptoms), allergic reaction, severe hypersensitivity reactions (cough, difficulty swallowing, rapid heartbeats, itching, swelling of eyelids or around the eyes, face, tongue, difficulty breathing, etc.), photosensitivity (sensitivity to sunlight), cross-sensitivity (allergy) with related chlorphenamine medications. Blood disorders (changes in the formula of blood cells, such as agranulocytosis, leukopenia, aplastic anemia, thrombocytopenia) with symptoms such as unusual bleeding, sore throat, or fatigue; low or high blood pressure, edema (swelling), ear alterations, impotence, menstrual alterations.
Paracetamol may damage the liver when taken in high doses or in prolonged treatments.
If you experience side effects, consult your doctor or pharmacist, even if they are side effects that do not appear in this prospectus.
Keep this medication out of the sight and reach of children.
Do not use Apogrip powder after the expiration date that appears on the packaging, after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medications at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medications. In this way, you will help protect the environment.
Composition of Apogrip tablets
Appearance of the product and contents of the packaging
Apogrip is a white, homogeneous, odorless powder with an orange flavor, presented in blisters that are packaged in cardboard containers with 10 blisters.
Holder of the marketing authorization and responsible for manufacturing
Aurovitas Spain S.A.U.
Avda. de Burgos, 16-D
28036 Madrid,
Spain
Responsible for manufacturing
Laboratorios Alcalá Farma, S.L.
Avenida de Madrid 82
28802 Alcalá de Henares (Madrid)
Last review date of this leaflet:February 2025
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.